A Vaccine (MV-s-NAP) for the Treatment of Patients With Invasive Metastatic Breast Cancer
Clinical trial NCT04521764 · RECRUITING
Trial details
- NCT number
- NCT04521764
- Sponsor
- Mayo Clinic
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-23
- Primary completion
- 2027-08-15
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.